NCT05488366View on ClinicalTrials.gov

Immunotherapy Combined With Radiotherapy for Metastatic Sarcoma

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

August 3, 2022

Primary Completion Date

June 27, 2025

Study Completion Date

August 31, 2026

Conditions
Sarcoma, Soft Tissue
Interventions
DRUG

Pembrolizumab

Given IV

RADIATION

Radiation therapy

Single target will be selected by the treating radiation oncologist. A lesion causing symptoms or expected to become symptomatic will be favored for target selection.

Trial Locations (1)

92868

Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange

All Listed Sponsors
lead

University of California, Irvine

OTHER